24 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
26522088	7	Interactions of a potent cyclic peptide inhibitor with the light chain of botulinum neurotoxin A: Insights from X-ray crystallography.	Brookhaven National Laboratory
26275678	11	Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A.	Stony Brook University
24984937	22	Benzoquinones as inhibitors of botulinum neurotoxin serotype A.	The Scripps Research Institute
24742203	47	Second generation steroidal 4-aminoquinolines are potent, dual-target inhibitors of the botulinum neurotoxin serotype A metalloprotease and P. falciparum malaria.	University Of Belgrade
24387280	63	Identification of clinically viable quinolinol inhibitors of botulinum neurotoxin A light chain.	The Scripps Research Institute
24360826	17	Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain.	The Scripps Research Institute
24290062	142	Small molecule inhibitors of anthrax lethal factor toxin.	Microbiotix
24074025	3	Investigating the selectivity of metalloenzyme inhibitors.	University Of California San Diego
23815186	1	4-Amino-7-chloroquinolines: probing ligand efficiency provides botulinum neurotoxin serotype A light chain inhibitors with significant antiprotozoal activity.	University Of Belgrade
23545109	30	Virtual medicinal chemistry: in silico pre-docking functional group transformation for discovery of novel inhibitors of botulinum toxin serotype A light chain.	Panthera Biopharma
23340139	27	Evaluation of adamantane hydroxamates as botulinum neurotoxin inhibitors: synthesis, crystallography, modeling, kinetic and cellular based studies.	The Scripps Research Institute
23484537	2	Paclitaxel is an inhibitor and its boron dipyrromethene derivative is a fluorescent recognition agent for botulinum neurotoxin subtype A.	Lakehead University And Thunder Bay Regional Research Institute
23565325	9	The C-terminus of Botulinum A Protease Has Profound and Unanticipated Kinetic Consequences Upon the Catalytic Cleft.	The Scripps Research Institute
20959871	2	Identification of a Natural Product Antagonist against the Botulinum Neurotoxin Light Chain Protease.	TBA
22516424	7	The synthesis of 2,5-bis(4-amidinophenyl)thiophene derivatives providing submicromolar-range inhibition of the botulinum neurotoxin serotype A metalloprotease.	University Of Belgrade
21116458	4	Pharmacophore Refinement Guides the Rational Design of Nanomolar-Range Inhibitors of the Botulinum Neurotoxin Serotype A Metalloprotease.	TBA
22542019	44	Reexamining hydroxamate inhibitors of botulinum neurotoxin serotype A: extending towards theß-exosite.	Fox Chase Chemical Diversity Center
20155918	72	Synthesis and biological evaluation of botulinum neurotoxin a protease inhibitors.	Microbiotix
22082667	67	Time-dependent botulinum neurotoxin serotype A metalloprotease inhibitors.	Microbiotix
21265542	2	A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.	University Of Belgrade
21421315	6	Synthesis and evaluation of library of betulin derivatives against the botulinum neurotoxin A protease.	The Scripps Research Institute
19528275	11	Identification and biochemical characterization of small-molecule inhibitors of Clostridium botulinum neurotoxin serotype A.	U.S. Army Medical Research Institute Of Infectious Diseases
19914829	7	Benzylidene cyclopentenediones: First irreversible inhibitors against botulinum neurotoxin A's zinc endopeptidase.	The Scripps Research Institute
19703771	6	Pharmacophore-guided lead optimization: the rational design of a non-zinc coordinating, sub-micromolar inhibitor of the botulinum neurotoxin serotype a metalloprotease.	National Cancer Institute At Frederick